EditorialEditorial

Should Rheumatologists Retain Ownership of Fibromyalgia?

YORAM SHIR and MARY-ANN FITZCHARLES
The Journal of Rheumatology April 2009, 36 (4) 667-670; DOI: https://doi.org/10.3899/jrheum.081073

REFERENCES

  1. 1.↵
    1. Wolfe F,
    2. Hawley DJ,
    3. Cathey MA,
    4. Caro X,
    5. Russell IJ
    . Fibrositis: Symptom frequency and criteria for diagnosis. An evaluation of 291 rheumatic disease patients and 58 normal individuals. J Rheumatol 1985;12:1159–63.
    OpenUrlPubMed
  2. 2.↵
    1. Ehrlich GE
    . Fibromyalgia, a virtual disease. Clin Rheumatol 2003;22:8–11.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Hadler NM
    . “Fibromyalgia” and the medicalization of misery”. J Rheumatol 2003;30:1668–70.
    OpenUrlFREE Full Text
  4. 4.↵
    1. Fitzcharles MA
    . Is fibromyalgia a distinct clinical entity? The approving rheumatologist’s evidence. Baillieres Best Pract Res Clin Rheumatol 1999;13:437–43.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Wolfe F,
    2. Smythe HA,
    3. Yunus MB,
    4. et al
    . The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990;33:160–72.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Wolfe F,
    2. Ross K,
    3. Anderson J,
    4. Russell IJ,
    5. Hebert L
    . The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;35:19–28.
    OpenUrl
  7. 7.
    1. McNally JD,
    2. Matheson DA,
    3. Bakowsky VS
    . The epidemiology of self-reported fibromyalgia in Canada. Chronic Dis Can 2006;27:9–16.
    OpenUrlPubMed
  8. 8.↵
    1. White KP,
    2. Speechley M,
    3. Harth M,
    4. Ostbye T
    . The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 1999;26:1570–6.
    OpenUrlPubMed
  9. 9.↵
    1. Pillemer SR,
    2. Bradley LA,
    3. Crofford LJ,
    4. Moldofsky H,
    5. Chrousos GP
    . The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum 1997;11:1928–39.
    OpenUrl
  10. 10.
    1. Yunus MB
    . Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum 2007;36:339–56.
    OpenUrlCrossRefPubMed
  11. 11.
    1. Perrot S,
    2. Dickenson AH,
    3. Bennett RM
    . Fibromyalgia: harmonizing science with clinical practice considerations. Pain Pract 2008;8:177–89.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Ablin J,
    2. Neumann L,
    3. Buskila D
    . Pathogenesis of fibromyalgia — a review. Joint Bone Spine 2008;75:273–9.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Bennett RM
    . The rational management of fibromyalgia patients. Rheum Dis Clin North Am 2002;28:181–99.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Shleyfer E,
    2. Jotkowitz A,
    3. Karmon A,
    4. Nevzorov R,
    5. Cohen H,
    6. Buskila D
    . Accuracy of the diagnosis of fibromyalgia by family physicians: is the pendulum shifting? J Rheumatol 2009;36:170–3.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Buskila D,
    2. Neumann L,
    3. Sibirski D,
    4. Shvartzman P
    . Awareness of diagnostic and clinical features of fibromyalgia among family physicians. Fam Pract 1997;14:238–41.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Fitzcharles MA,
    2. Esdaile JM
    . The overdiagnosis of fibromyalgia syndrome. Am J Med 1997;103:44–50.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Fitzcharles MA,
    2. Boulos P
    . Inaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals. Rheumatology 2003;42:263–7.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Croft P,
    2. Rigby AS,
    3. Boswell R,
    4. Schollum J,
    5. Silman A
    . The prevalence of chronic widespread pain in the general population. J Rheumatol 1993;20:710–3.
    OpenUrlPubMed
  19. 19.↵
    1. Price DD,
    2. Staud R
    . Neurobiology of fibromyalgia syndrome. J Rheumatol 2005;32 Suppl 75:22–80.
    OpenUrl
  20. 20.↵
    1. Gibson SJ,
    2. Littlejohn GO,
    3. Gorman MM,
    4. Helme RD,
    5. Granges G
    . Altered heat pain thresholds and cerebral event-related potentials following painful CO2 laser stimulation in subjects with fibromyalgia syndrome. Pain 1994;58:185–93.
    OpenUrlCrossRefPubMed
  21. 21.
    1. Russell IJ,
    2. Orr MD,
    3. Littman B,
    4. et al
    . Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994;37:1593–601.
    OpenUrlCrossRefPubMed
  22. 22.
    1. Gracely RH,
    2. Petzke F,
    3. Wolf JM,
    4. Clauw DJ
    . Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002;46:1333–43.
    OpenUrlCrossRefPubMed
  23. 23.
    1. Julien N,
    2. Goffaux P,
    3. Arsenault P,
    4. Marchand S
    . Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 2005;114:295–302.
    OpenUrlCrossRefPubMed
  24. 24.
    1. Griep EN,
    2. Boersma JW,
    3. Kloet ER
    . Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 1993;20:469–74.
    OpenUrlPubMed
  25. 25.↵
    1. Petzke F,
    2. Clauw DJ
    . Sympathetic nervous system function in fibromyalgia. Curr Rheumatol Rep 2000;2:116–23.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Hughes G,
    2. Martinez C,
    3. Myon E,
    4. Taieb C,
    5. Wessely S
    . The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheum 2006;54:177–83.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Goldenberg DL,
    2. Burckhardt C,
    3. Crofford L
    . Management of fibromyalgia syndrome. JAMA 2004;292:2388–9.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Mease P,
    2. Arnold LM,
    3. Bennett R,
    4. et al
    . Fibromyalgia syndrome. J Rheumatol 2007;34:1415–25.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Burckhardt C,
    2. Goldenberg D,
    3. et al
    Fibromyalgia Syndrome Pain Management Guideline Panel 2002–2005, Burckhardt C, Goldenberg D, et al. Guideline for the management of fibromyalgia pain in adults and children: APS clinical practice guideline series. No. 4. Glenview, IL: American Pain Society; 2005.
  30. 30.↵
    1. Carville SF,
    2. Arendt-Nielsen S,
    3. Bliddal H,
    4. et al
    . EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 2008;67:536–41.
    OpenUrlAbstract/FREE Full Text
  31. 31.
    1. Sim J,
    2. Adams N
    . Systematic review of randomized controlled trials of nonpharmacological interventions for fibromyalgia. Clin J Pain 2002;18:324–36.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Oliver K,
    2. Cronan T,
    3. Walen A
    . A review of multidisciplinary interventions for fibromyalgia patients: Where do we go from here? J Musculoskeletal Pain 2001;9:63–80.
    OpenUrlCrossRef
  33. 33.↵
    1. Scascighini L,
    2. Toma V,
    3. Dober-Spielmann S,
    4. Sprott H
    . Multidisciplinary treatment for chronic pain: a systematic review of interventions and outcomes. Rheumatology 2008;47:670–8.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    1. Barkhuizen A
    . Rational and targeted pharmacologic treatment of fibromyalgia. Rheum Dis Clin North Am 2002;28:261–90.
    OpenUrlCrossRefPubMed
  35. 35.
    1. Crofford LJ
    . Pain management in fibromyalgia. Curr Opin Rheumatol 2008;20:246–50.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Fishbain D
    . Evidence-based data on pain relief with antidepressants. Ann Med 2000;32:305–16.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

 Request Permissions

Save to my folders

Jump to section